Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
GRCL
Fundamentals

Gracell Biotechnologies Inc.

GRCL

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

1.38B
▼-278.39M▼-16.81%
6 Months Change

Liabilities

241.17M
▼-39.34M▼-14.03%
6 Months Change

Free Cash Flow

-531.04M
▼-169.74M▼-46.98%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2023-04-25
Form 20-F
ID: 0001104659-23-049599
2022-04-22
Form 20-F
ID: 0001193125-22-115083
2021-04-23
Form 20-F
ID: 0001193125-21-128979